TDACU
Translational Development Acquisition Corp.
NasdaqGMUSDEQUITY
Financial Services
DELAYED
Last price
12.89
■ 0.00 (0.00%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
—
Prev close
12.89
Day high
12.89
Day low
12.89
Volume
3
Market cap
—
P/E (TTM)
—
52W range
10.36 – 17.29
Trailing performance
Returnvs SPY
1W
0.00%
+1.4%
1M
+8.83%
+5.1%
3M
+20.40%
+17.3%
6M
+20.40%
+9.3%
YTD
+20.40%
+8.1%
1Y
+21.33%
+1.3%
3Y
—
-74.2%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on TDACU open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
0
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| May 29, 18 | PONOMAREV ILYA Officer |
STATEMENT | 2.39M | — | Indirect |
| May 29, 18 | GALLAGHER THOMAS JOHN Director |
STATEMENT | 1.00M | — | Indirect |
| May 29, 18 | BUTKEVYCH GENNADII Director |
STATEMENT | 500.00K | — | Indirect |
| May 29, 18 | KOMISSAROV VADIM Officer |
STATEMENT | 15.00K | — | Direct |
| May 29, 18 | VERONA EDWARD S Officer |
STATEMENT | 20.00K | — | Direct |
| May 29, 18 | GALLAGHER THOMAS JOHN Director |
STATEMENT | 3.00K | — | Direct |
| May 29, 18 | KOMISSAROV VADIM Officer |
STATEMENT | 100.00K | — | Indirect |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
BUTKEVYCH GENNADII |
Director | — | Ownership Statement |
GALLAGHER THOMAS JOHN |
Director | 3.00K | Ownership Statement |
KOMISSAROV VADIM |
Officer | 15.00K | Ownership Statement |
PONOMAREV ILYA |
Officer | — | Ownership Statement |
VERONA EDWARD S |
Officer | 20.00K | Ownership Statement |
Fundamentals
Market cap—
Enterprise value$276.39M
Revenue (TTM)—
Gross profit—
EBITDA—
Net income$5.54M
EPS (TTM)—
Free cash flow$-355.05K
Total cash$85.88K
Total debt$1.10M
Book value / share$-0.31
Shares outstanding—
Float15.95M
Short % of float—
Dividend yield—
Beta (5Y)—
Valuation & profitability ratios
Trailing P/E—
Forward P/E—
PEG ratio—
Price / sales—
Price / book—
EV / revenue—
EV / EBITDA—
Gross margin0.00%
Operating margin0.00%
Profit margin0.00%
Return on equity—
Return on assets-0.49%
Debt / equity—
Current ratio0.06
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | YoY |
|---|---|---|---|---|
| Total revenue | $0 | $0 | $0 | — |
| Operating revenue | $0 | $0 | $0 | — |
| Selling, general & admin | $944.54K | $196.36K | $485.55K | +381.0% |
| Total operating expense | $944.54K | $196.36K | $485.55K | +381.0% |
| Operating income | -$944.54K | -$196.36K | -$485.55K | -381.0% |
| Pre-tax income | $6.36M | -$71.01K | -$485.55K | +9,059.7% |
| Net income | $6.36M | -$71.01K | -$485.55K | +9,059.7% |
| Net income to common | $6.36M | -$71.01K | -$485.55K | +9,059.7% |
| EBIT | -$944.54K | -$196.36K | -$485.55K | -381.0% |
| EBITDA | -$944.54K | -$196.36K | -$485.55K | -381.0% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $29.79K | $438.17K | $2.02K | $2.23K | -93.2% |
| Cash & short-term investments | $29.79K | $438.17K | $2.02K | $2.23K | -93.2% |
| Total current assets | $39.47K | $650.23K | $2.02K | $54.23K | -93.9% |
| Total assets | $181.70M | $175.00M | $2.02K | $437.24K | +3.8% |
| Total current liabilities | $544.07K | $210.30K | $509.68K | $459.39K | +158.7% |
| Current debt | $200.00K | — | $347.50K | $259.00K | — |
| Total debt | $200.00K | — | $347.50K | $259.00K | — |
| Total liabilities | $6.58M | $6.25M | $509.68K | $459.34K | +5.3% |
| Retained earnings | -$6.54M | -$5.60M | -$532.66K | -$47.11K | -16.9% |
| Shareholder equity | $175.12M | $168.75M | -$507.66K | -$22.11K | +3.8% |
| Working capital | -$504.61K | $439.93K | -$507.66K | -$405.17K | -214.7% |
| Net tangible assets | $175.12M | $168.75M | -$507.66K | -$22.11K | +3.8% |
| Shares issued | 21.91M | 21.91M | 19.66M | 19.66M | 0.0% |
| Line item | 2025 | 2024 | 2023 | YoY |
|---|---|---|---|---|
| Net income | $6.36M | -$71.01K | -$485.55K | +9,059.7% |
| Change in working capital | $336.15K | -$659.81K | $3.01K | +150.9% |
| Operating cash flow | -$608.39K | -$851.45K | -$204 | +28.5% |
| Investing cash flow | $0 | -$174.22M | $0 | +100.0% |
| Financing cash flow | $200.00K | $175.51M | $0 | -99.9% |
| Free cash flow | -$608.39K | -$851.45K | -$204 | +28.5% |
| End cash position | $29.79K | $438.17K | $2.02K | -93.2% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $0 | $0 | $0 | $0 | $0 | — |
| Operating revenue | $0 | $0 | $0 | $0 | $0 | — |
| Selling, general & admin | $281.16K | $162.34K | $213.66K | $221.13K | $347.41K | +73.2% |
| Total operating expense | $281.16K | $162.34K | $213.66K | $221.13K | $347.41K | +73.2% |
| Operating income | -$281.16K | -$162.34K | -$213.66K | -$221.13K | -$347.41K | -73.2% |
| Net interest income | — | — | $1.87M | — | — | — |
| Pre-tax income | $1.33M | $1.60M | $1.66M | $1.62M | $1.48M | -16.5% |
| Net income | $1.33M | $1.60M | $1.66M | $1.62M | $1.48M | -16.5% |
| Net income to common | $1.33M | $1.60M | $1.66M | $1.62M | $1.48M | -16.5% |
| EBIT | -$281.16K | -$162.34K | -$213.66K | -$221.13K | -$347.41K | -73.2% |
| EBITDA | -$281.16K | -$162.34K | -$213.66K | -$221.13K | -$347.41K | -73.2% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $24.63K | $29.79K | $47.15K | $35.26K | $206.60K | -17.3% |
| Cash & short-term investments | $24.63K | $29.79K | $47.15K | $35.26K | $206.60K | -17.3% |
| Total current assets | $75.32K | $39.47K | $80.58K | $156.08K | $415.42K | +90.8% |
| Total assets | $183.35M | $181.70M | $179.98M | $178.18M | $176.60M | +0.9% |
| Total current liabilities | $861.09K | $544.07K | $422.85K | $284.68K | $322.90K | +58.3% |
| Current debt | $500.00K | $200.00K | $100.00K | — | — | +150.0% |
| Total debt | $500.00K | $200.00K | $100.00K | — | — | +150.0% |
| Total liabilities | $6.90M | $6.58M | $6.46M | $6.32M | $6.36M | +4.8% |
| Retained earnings | -$6.82M | -$6.54M | -$6.38M | -$6.17M | -$5.95M | -4.3% |
| Shareholder equity | $176.45M | $175.12M | $173.52M | $171.86M | $170.24M | +0.8% |
| Working capital | -$785.77K | -$504.61K | -$342.26K | -$128.60K | $92.52K | -55.7% |
| Net tangible assets | $176.45M | $175.12M | $173.52M | $171.86M | $170.24M | +0.8% |
| Shares issued | 21.91M | 21.91M | 21.91M | 21.91M | 21.91M | 0.0% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Net income | $1.33M | $1.60M | $1.66M | $1.62M | $1.48M | -16.5% |
| Change in working capital | -$24.00K | $44.98K | $125.55K | $49.78K | $115.83K | -153.3% |
| Operating cash flow | -$305.16K | -$117.36K | -$88.11K | -$171.34K | -$231.57K | -160.0% |
| Financing cash flow | $300.00K | $100.00K | $100.00K | $0 | $0 | +200.0% |
| Free cash flow | -$305.16K | -$117.36K | -$88.11K | -$171.34K | -$231.57K | -160.0% |
| End cash position | $24.63K | $29.79K | $47.15K | $35.26K | $206.60K | -17.3% |
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $0 | — |
| Next quarter | — | — | $0 | — |
| Current year | — | — | $0 | — |
| Next year | — | — | $0 | — |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
ConsensusNONE
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders0.00%
Held by institutions1.06%
Institutions holding4
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
12.57
+2.54% from price
SMA 20
12.52
+0.41% from price
SMA 50
12.02
+4.57% from price
SMA 100
11.47
+12.35% from price
SMA 200
10.96
+14.73% from price
EMA 12
12.53
+2.87% from price
EMA 26
12.36
+4.31% from price
EMA 50
12.09
+6.65% from price
RSI (14)
63.2
Neutral
MACD (12,26,9)
0.17
Hist -0.02
ATR (14)
0.00
—
Realised vol 30D
26.9%
Annualised
Bollinger upper
12.96
20, 2σ
Bollinger lower
12.07
20, 2σ
50 / 200 cross
Golden
12.02 vs 10.96
Trend bias
Above 200
+14.73%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.19
Less volatile than market
Correlation to SPY
0.03
Largely independent
Realised vol 30D
26.9%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-38.1%
Peak to trough
Max drawdown 5Y
-38.1%
Peak to trough
ATR 14
0.00
Average true range
Beta (reported)
—
5Y monthly, from filing
Short interest
Shares short
1
Prior 1
Change vs prior
0.0%
Shorts covering
% of float
—
—
% of shares out
—
Against total outstanding
Days to cover
0.0
Liquid
Float
15.95M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
SEC filings
Corporate Changes & Voting Matters
8-K · 2024-12-31
Corporate Changes & Voting Matters
8-K · 2024-12-27
A correspondence can be sent as a document with another submission type or can be sent as a separate submission
CORRESP · 2024-12-19
A correspondence can be sent as a document with another submission type or can be sent as a separate submission
CORRESP · 2024-11-19
A correspondence can be sent as a document with another submission type or can be sent as a separate submission
CORRESP · 2024-10-21
Headlines
Translational Development Acquisition, Prologium Secure $50 Million Primary Capital Investment
MT Newswires · 27d ago
ProLogium and Translational Development Acquisition Corp. Announce $50 Million Committed Primary Capital Investment to Support Proposed Business Combination
GlobeNewswire · 27d ago
TDAC Announces ProLogium's Filing of F-4 As Continuing Momentum Towards Merger
PR Newswire · 49d ago
TDAC Announces Very Successful Share Redemption Results in Connection with Extension Vote
PR Newswire · 63d ago
Battery maker ProLogium to list on Nasdaq in $3.8 billion SPAC deal
Reuters · 89d ago
ProLogium, a Next Generation Solid-State Battery Developer with 10+ Years of Proven Commercialization, to List on the Nasdaq through a Merger with Translational Development Acquisition Corp.
GlobeNewswire · 89d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.